EPS for Leucadia National (LUK) Expected At $0.43; 2 Analysts Bullish SORRENTO TECH COM USD0.001 (ROKA)

March 24, 2018 - By Hazel Jackson

Among 5 analysts covering Roka Bioscience (NASDAQ:ROKA), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Roka Bioscience had 9 analyst reports since August 14, 2015 according to SRatingsIntel. Roth Capital initiated SORRENTO TECH INC COM USD0.001 (NASDAQ:ROKA) on Tuesday, December 13 with “Buy” rating. TH Capital initiated it with “Buy” rating and $10 target in Tuesday, December 13 report. On Tuesday, September 8 the stock rating was upgraded by Zacks to “Hold”. The rating was maintained by Leerink Swann on Friday, August 14 with “Outperform”. As per Tuesday, August 25, the company rating was downgraded by Zacks. Leerink Swann downgraded it to “Market Perform” rating and $1 target in Monday, March 7 report. See SORRENTO TECH INC COM USD0.001 (NASDAQ:ROKA) latest ratings:

Analysts expect Leucadia National Corporation (NYSE:LUK) to report $0.43 EPS on April, 26.They anticipate $0.32 EPS change or 42.67% from last quarter’s $0.75 EPS. LUK’s profit would be $153.19 million giving it 12.70 P/E if the $0.43 EPS is correct. After having $0.48 EPS previously, Leucadia National Corporation’s analysts see -10.42% EPS growth. The stock decreased 2.28% or $0.51 during the last trading session, reaching $21.85. About 2.88 million shares traded or 58.62% up from the average. Leucadia National Corporation (NYSE:LUK) has risen 38.50% since March 24, 2017 and is uptrending. It has outperformed by 21.80% the S&P500.

Leucadia National Corporation operates as a diversified holding firm that focuses on financial service businesses and investments in the Americas, Europe, and Asia. The company has market cap of $7.78 billion. The Company’s services include equities research, sales, and trading; financing, securities lending, and other brokerage; wealth management; fixed income sales and trading; futures; equity capital markets, debt capital markets, and financial advisory; and asset management services. It has a 48.56 P/E ratio. The firm also provides online foreign exchange trading, contract for difference trading, spread betting, and related services.

Investors sentiment increased to 1.15 in 2017 Q3. Its up 0.24, from 0.91 in 2017Q2. It improved, as 35 investors sold Leucadia National Corporation shares while 150 reduced holdings. 52 funds opened positions while 117 raised stakes. 261.70 million shares or 0.63% less from 263.35 million shares in 2017Q2 were reported. Sector Pension Investment Board accumulated 15,756 shares. Daiwa Securities Gp has 9,063 shares for 0% of their portfolio. Bluecrest Cap Ltd has 86,624 shares. Arlington Value Capital Lc holds 9.23% of its portfolio in Leucadia National Corporation (NYSE:LUK) for 3.65 million shares. Barclays Plc holds 106,975 shares. Smithfield Trust Com holds 0.04% or 11,500 shares in its portfolio. Frontier Cap Mgmt Ltd accumulated 879,912 shares or 0.16% of the stock. Zurcher Kantonalbank (Zurich Cantonalbank) holds 366,670 shares or 0.09% of its portfolio. Belgium-based Kbc Gru Nv has invested 0.01% in Leucadia National Corporation (NYSE:LUK). Contravisory Investment Mgmt stated it has 10,921 shares or 0.1% of all its holdings. Td Asset Mgmt owns 496,843 shares. Martingale Asset Ltd Partnership stated it has 0.04% of its portfolio in Leucadia National Corporation (NYSE:LUK). Dnb Asset Management As holds 0.01% or 30,740 shares in its portfolio. Jpmorgan Chase, a New York-based fund reported 1.64 million shares. State Board Of Administration Of Florida Retirement Systems owns 483,886 shares or 0.03% of their US portfolio.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: